NCT02127320View on ClinicalTrials.gov

Investigating the Pharmacokinetic Drug Interactions Between Rosuvastatin and Ezetimibe

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

September 30, 2014

Study Completion Date

November 30, 2014

Conditions
Healthy
Interventions
DRUG

Rosuvastatin 20mg

DRUG

Ezetimibe 10mg

DRUG

Rosuvastatin 20mg + Ezetimibe 10mg

Trial Locations (1)

Unknown

Asan Medical Center, Seoul, Korea, Republic of

Sponsors
All Listed Sponsors
lead

Hanmi Pharmaceutical Company Limited

INDUSTRY

NCT02127320 - Investigating the Pharmacokinetic Drug Interactions Between Rosuvastatin and Ezetimibe | Biotech Hunter | Biotech Hunter